Wikipedia -WSS

Wikipedia

author：fashion 2025-10-01 15:30:55 - browse：1

Eli Lilly headquarters — Kristoffer Tripplaar/AP

The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with the condition lose 15.7% of their body weight in a clinical trial, a result that Wall Street analysts expect to pave the way for the therapy’s approval as a weight loss treatment.

Mounjaro is the latest drug in a class known as GLP-1s or incretins — the same class as Novo Nordisk’s Ozempic, which has become a sensation because of its ability to help patients lose weight. Mounjaro has shown the potential to lead to even greater weight loss than Ozempic, and industry experts expect that it will eventually generate many billions of dollars in annual sales. Analysts at SVB Securities projected in December that Mounjaro sales could reach $26.4 billion by 2030.

Eli Lilly on Thursday also announced quarterly earnings of $1.64 per share, adjusted for one-time items, slightly below analyst expectations, on sales of $6.96 billion. Sales were hurt because of a comparison to a year ago, when the company’s Covid-19 monoclonal antibodies were still on the market. Mounjaro sales for the first quarter were $586 million, largely for people with diabetes, compared to an analyst consensus of $433.2 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Dogs on Prozac: What pet anti

WSS

Why drug prescriptions should include diagnoses

Bird flu in milk supply is likely coming from asymptomatic cows

Cell therapy fails to slow type 1 diabetes, but safety is established

The strategy behind pharma's lawsuits over drug pricing reform

Why drug prescriptions should include diagnoses

MassMutual is introducing free genetic testing for members

entertainment

Wikipedia

entertainment

Peter Hotez and the public health issue of online harassment

Why drug prescriptions should include diagnoses

DIEP, the 'gold standard' of breast reconstruction, is under threat

Death of patient in Alzheimer’s trial raises question of possible risks

The high cost of giving birth even with insurance

Why we need to separate burnout from moral injury in health care

The cancer drug shortage isn’t new — and neither are the solutions

Exact Sciences stock tumbles despite strong cancer detection sales

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

explore

Colonoscopy at 40? Study finds a possible benefit

What would happen to your eyes if you looked at the solar eclipse?

Why drug prescriptions should include diagnoses

MassMutual is introducing free genetic testing for members

WATCH: Why do fingernails fall off when they're damaged?

Cancer researcher Catriona Jamieson is sending tumors into space

focus

focus

focus

leisure time